Beyond clinical risk scores in pulmonary arterial hypertension: does invasive hemodynamic assessment provide additional value?

作者
A Henriques Silva,S Alegria,Paula Fazendas,F Ferreira,B Ferreira,A C Vieira,Débora Repolho,J Mirinha Luz,A Pereira,Otília Simões,H Pereira
出处
期刊:European Journal of Heart Failure [Elsevier BV]
卷期号:28 (Supplement_2)
标识
DOI:10.1093/ejhf/xuag193.1258
摘要

Abstract Background Accurate risk stratification in pulmonary arterial hypertension (PAH) is essential for prognosis and treatment selection. Current multiparametric scores, such as REVEAL Lite and COMPERA, rely predominantly on clinical and biochemical variables, without incorporating invasive hemodynamic markers that are known strong predictors of outcome. Purpose To determine whether invasive hemodynamic variables provide incremental prognostic value beyond established clinical risk scores in PAH. Methods We prospectively followed 78 PAH patients (pts) for 12 months in a referral center. The composite endpoint included death, lung transplantation, initiation of intravenous prostanoids, or unscheduled hospitalization. Baseline right-heart catheterization was performed according to current guidelines. Prognostic associations were assessed using Cox models, and survival distributions were compared with Kaplan–Meier analysis. Results Mean age at diagnosis was 52.3 ± 17.2 years, and 69.2% were female (n=54). WHO functional class III–IV was present in 79.5% of pts. Fourteen pts (18%) reached the composite endpoint. In univariate analysis, REVEAL Lite (HR 1.56, p=0.004) and COMPERA (HR 4.97, p=0.003) were significantly associated with adverse outcomes. Among hemodynamic variables, right-atrial pressure (RAP; p=0.010) and SvO₂ (p=0.003) were significant predictors, and pulmonary arterial compliance (PAC) showed a borderline association (p=0.066). In multivariable models including REVEAL, Cox regression identified three independent predictors: higher RAP (HR 1.17; 95% CI 1.05–1.29; p=0.003), lower PAC (HR 19.43; 95% CI 1.86–202.63; p=0.013), and higher REVEAL score (HR 1.54; 95% CI 1.12–2.12; p=0.003). In the model including COMPERA, independent predictors were RAP (HR 1.19; 95% CI 1.07–1.33; p=0.002), PAC (HR 15.79; 95% CI 1.44–172.64; p=0.024), and COMPERA score (HR 3.86; 95% CI 1.16–12.84; p=0.027). Clinically meaningful increments showed that each 1-mmHg increase in RAP conferred a 17–19% increase in hazard, and that PAC remained a very strong predictor in both models. In the REVEAL intermediate-risk subgroup, SvO₂ and RAP provided significant prognostic discrimination (Log-Rank p=0.005 and p=0.027, respectively) (Figure 1). Conclusions RAP, SvO₂, and PAC significantly enhance risk discrimination beyond REVEAL and COMPERA, supporting the integration of invasive hemodynamics into routine multiparametric risk assessment.For image description, please refer to the figure legend and surrounding text.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
大方的冥茗完成签到 ,获得积分10
1秒前
我是一片云完成签到,获得积分10
1秒前
自然友灵完成签到,获得积分10
1秒前
roking完成签到,获得积分10
1秒前
小马甲的应助被闾丘翠桃采纳,获得10
2秒前
狐狸的贝完成签到,获得积分10
2秒前
2秒前
安详晓亦完成签到,获得积分10
2秒前
2秒前
牛牛完成签到,获得积分10
3秒前
3秒前
coff完成签到,获得积分10
5秒前
6秒前
研友_ZG4ml8发布了新的文献求助10
6秒前
学术的刘完成签到,获得积分10
6秒前
Allen完成签到,获得积分10
7秒前
牧芷珊完成签到,获得积分10
7秒前
阿柠完成签到,获得积分10
7秒前
研友_Zbb4mZ完成签到,获得积分10
7秒前
三七二一完成签到,获得积分10
7秒前
8秒前
JamesPei的应助被爱在西元前采纳,获得10
8秒前
奋斗蝴蝶发布了新的文献求助10
9秒前
陈zw完成签到,获得积分10
9秒前
9秒前
zzzzlllll完成签到,获得积分10
9秒前
Sue完成签到,获得积分10
10秒前
rrr完成签到,获得积分10
10秒前
ZYX完成签到,获得积分10
10秒前
喜悦白玉发布了新的文献求助10
11秒前
ZJ完成签到,获得积分10
11秒前
11秒前
wanci的应助被瘦瘦滢采纳,获得10
11秒前
拉普拉斯开始变换完成签到,获得积分10
11秒前
molihuakai的应助被方苠采纳,获得10
11秒前
feiyue126发布了新的文献求助10
11秒前
12秒前
skmksd发布了新的文献求助10
12秒前
登山者完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039